{"DataElement":{"publicId":"2542173","version":"1","preferredName":"Miller and Payne Malignant Neoplasm Response Classification Grade","preferredDefinition":"Grade from a classification system that includes the primary tumor and the status of the axillary lymph nodes (ALN), with comparison of negative nodes with those that have already responded to therapy.","longName":"MP_MALIG_DZ_RESP_GD","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2225398","version":"1","preferredName":"Event Disease Response","preferredDefinition":"information relating to disease event response.","longName":"EVENT_DISEASE_RESP","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2225396","version":"1","preferredName":"Event Diseases and Disorders","preferredDefinition":"Event; something that happens at a given place and time.:A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C25499:C2991","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Event","conceptCode":"C25499","definition":"Something that happens at a given place and time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F600421C-67F8-0246-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-09","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-05-09","modifiedBy":"ONEDATA","dateModified":"2005-05-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177336","version":"1","preferredName":"Response","preferredDefinition":"Response; a bodily process occurring due to the effect of some foregoing stimulus or agent.","longName":"Response","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Response","conceptCode":"C25755","definition":"Any act or phenomena, or behavior, constituting a reply or reaction of a living organism or its part to some foregoing stimulus or agent.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-528C-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":"Denise Warzel updated Definition by seraching NCI Thesaurus in Admin tool.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F600421C-67FA-0246-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-09","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-05-09","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2542171","version":"1","preferredName":"Miller and Payne Malignant Neoplasm Response Classification Grade","preferredDefinition":"Miller and Payne grading scale for pathological responses, combining primary tumor and axillary lymph nodes in grading a pathological remission status. \r\n","longName":"MP_MALIG_RESP_GD","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"40","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Grade 1","valueDescription":"Some alteration to individual malignant cells but no reduction in overall number","ValueMeaning":{"publicId":"2581929","version":"1","preferredName":"Some alteration to individual malignant cells but no reduction in overall number","longName":"2581929","preferredDefinition":"Some alteration to individual malignant cells but no reduction in overall number","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0D16-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-14","modifiedBy":"REEVESD","dateModified":"2006-11-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"223C5F04-EB54-408E-E044-0003BA3F9857","beginDate":"2006-11-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-14","modifiedBy":"REEVESD","dateModified":"2006-11-14","deletedIndicator":"No"},{"value":"Grade 2","valueDescription":"Minor loss of invasive tumor cells but overall cellularity still high","ValueMeaning":{"publicId":"2581930","version":"1","preferredName":"Minor loss of invasive tumor cells but overall cellularity still high","longName":"2581930","preferredDefinition":"Minor loss of invasive tumor cells but overall cellularity still high","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0D17-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-14","modifiedBy":"REEVESD","dateModified":"2006-11-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"223C5F04-EB60-408E-E044-0003BA3F9857","beginDate":"2006-11-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-14","modifiedBy":"REEVESD","dateModified":"2006-11-14","deletedIndicator":"No"},{"value":"Grade 3","valueDescription":"Moderate reduction in tumor cells up to an estimated 90% loss","ValueMeaning":{"publicId":"2581931","version":"1","preferredName":"Moderate reduction in tumor cells up to an estimated 90% loss","longName":"2581931","preferredDefinition":"Moderate reduction in tumor cells up to an estimated 90% loss","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0D18-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-14","modifiedBy":"REEVESD","dateModified":"2006-11-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"223C5F04-EB6C-408E-E044-0003BA3F9857","beginDate":"2006-11-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-14","modifiedBy":"REEVESD","dateModified":"2006-11-14","deletedIndicator":"No"},{"value":"Grade 4","valueDescription":"Marked disappearance of invasive tumor cells such that only small clusters of widely dispersed cells detected","ValueMeaning":{"publicId":"2581932","version":"1","preferredName":"Marked disappearance of invasive tumor cells such that only small clusters of widely dispersed cells detected","longName":"2581932","preferredDefinition":"Marked disappearance of invasive tumor cells such that only small clusters of widely dispersed cells detected","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0D19-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-14","modifiedBy":"REEVESD","dateModified":"2006-11-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"223C5F04-EB78-408E-E044-0003BA3F9857","beginDate":"2006-11-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-14","modifiedBy":"REEVESD","dateModified":"2006-11-14","deletedIndicator":"No"},{"value":"Grade 5 (pCR of the primary tumor)","valueDescription":"No invasive cells identifiable in sections from the site of the previous tumor","ValueMeaning":{"publicId":"2581933","version":"1","preferredName":"No invasive cells identifiable in sections from the site of the previous tumor","longName":"2581933","preferredDefinition":"No invasive cells identifiable in sections from the site of the previous tumor","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0D1A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-14","modifiedBy":"REEVESD","dateModified":"2006-11-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"223C5F04-EB84-408E-E044-0003BA3F9857","beginDate":"2006-11-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-14","modifiedBy":"REEVESD","dateModified":"2006-11-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008550","version":"1","preferredName":"Disease Response","preferredDefinition":"the response criteria (includes RECIST and others) and associated documentation of disease.","longName":"DZ_RESP","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22C0651-216B-5273-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2542170","version":"1","preferredName":"Malignant Neoplasm Response Classification Grade","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004:In medicine, an improvement related to treatment.:A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.:A position on a scale of intensity or amount or quality.","longName":"C9305:C50995:C25161:C48309","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Disease Response","conceptCode":"C50995","definition":"The pathologic and/or clinical changes that result from treatment. The changes may include eradication of detectable disease, stabilization of disease, or disease progression.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"223C5F28-1D8F-3D42-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-14","modifiedBy":"ONEDATA","dateModified":"2006-11-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"223C5F28-1DA0-3D42-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-14","modifiedBy":"SBR","dateModified":"2008-12-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Miller and Payne Classificati","type":"Preferred Question Text","description":"Miller and Payne Classification for the tumor","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"223C75D6-2099-433C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-14","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-11-14","modifiedBy":"REEVESD","dateModified":"2007-06-22","changeDescription":"Curated to support Univ Arkansas Medical Services adoption of C3D.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}